Last week, the U.S. Department of Justice granted conditional approval to the $69 billion merger of Aetna and CVS pending the sale of WellCare Health, Aetna’s Part D prescription drug…
Stay informed with Paul’s unique perspective on healthcare happenings, from policies and politics to innovations and investments. Subscribe today to the Keckley Report and be the first to receive Paul’s weekly insights and special reports.